tiprankstipranks
Advertisement
Advertisement
Arrowhead Pharmaceuticals Adds Experienced Healthcare Investor to Board
PremiumCompany AnnouncementsArrowhead Pharmaceuticals Adds Experienced Healthcare Investor to Board
1M ago
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
Premium
TipRanks Newswire
Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)
2M ago
Arrowhead’s Inhaled ARO-RAGE Asthma Trial Enters Active Recruitment, Keeping a Key Pipeline Catalyst in Play
Premium
Company Announcements
Arrowhead’s Inhaled ARO-RAGE Asthma Trial Enters Active Recruitment, Keeping a Key Pipeline Catalyst in Play
2M ago
Arrowhead’s ARO-CFB Kidney Trial Completion: What Investors Should Watch Next
PremiumCompany AnnouncementsArrowhead’s ARO-CFB Kidney Trial Completion: What Investors Should Watch Next
2M ago
Arrowhead price target raised to $46 from $35 at Bernstein
Premium
The Fly
Arrowhead price target raised to $46 from $35 at Bernstein
2M ago
Arrowhead Pharmaceuticals’ Earnings Call: Launch, Losses, Bets
Premium
Company Announcements
Arrowhead Pharmaceuticals’ Earnings Call: Launch, Losses, Bets
2M ago
Arrowhead announces Australian TGA approved Redemplo for FCS
PremiumThe FlyArrowhead announces Australian TGA approved Redemplo for FCS
3M ago
Arrowhead initiated with an Overweight at JPMorgan
Premium
The Fly
Arrowhead initiated with an Overweight at JPMorgan
3M ago
Arrowhead, Astera, Exxon, Intel, Halliburton Trending With Analysts
Premium
Weekend Updates
Arrowhead, Astera, Exxon, Intel, Halliburton Trending With Analysts
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100